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Developmental cortical malformations comprise a large spectrum of histopathological
brain abnormalities and syndromes. Their genetic, developmental and clinical complexity
suggests they should be better understood in terms of the complementary action
of independently timed perturbations (i.e., the multiple-hit hypothesis). However,
understanding the underlying biological processes remains puzzling. Here we induced
developmental cortical malformations in offspring, after intraventricular injection of
methylazoxymethanol (MAM) in utero in mice. We combined extensive histological and
electrophysiological studies to characterize the model. We found that MAM injections
at E14 and E15 induced a range of cortical and hippocampal malformations resembling
histological alterations of specific genetic mutations and transplacental mitotoxic agent
injections. However, in contrast to most of these models, intraventricularly MAM-injected
mice remained asymptomatic and showed no clear epilepsy-related phenotype as tested
in long-term chronic recordings and with pharmacological manipulations. Instead, they
exhibited a non-specific reduction of hippocampal-related brain oscillations (mostly in
CA1); including theta, gamma and HFOs; and enhanced thalamocortical spindle activity
during non-REM sleep. These data suggest that developmental cortical malformations do
not necessarily correlate with epileptiform activity. We propose that the intraventricular
in utero MAM approach exhibiting a range of rhythmopathies is a suitable model for
multiple-hit studies of associated neurological disorders.
Keywords: oscillations, multi-site recordings, hippocampal heterotopia, epilepsy
INTRODUCTION
Brain structural specificity emerges during early development
through elaborated genetic programs that control cell prolifer-
ation, differentiation, migration and the formation of microcir-
cuits in close interaction with environmental factors (Rubenstein
and Rakic, 2013). Malformations of cortical development result
from disruptions in this intricate process and include a myriad
of structural abnormalities. Malformations are grouped accord-
ing to whether they are likely to reflect alterations secondary
to abnormal neuronal and glial proliferation or apoptosis (e.g.,
focal cortical dysplasia with balloon cells), neuronal migration
(lissensephaly and heterotopias) and postmigrational develop-
ment (polymicrogyria and cortical dysplasia without balloon
cells) (Barkovich et al., 2012). Clinically, malformations of cor-
tical development are strongly associated with a spectrum of
early-onset neurological diseases, including epilepsy, autism and
intellectual disability (Norman et al., 1995; Sisodiya, 2004).
Many types of malformations of cortical development are
linked with genetic mutations while others remain only clini-
cally defined. In a recent comprehensive classification system,
the emphasis is placed on a more accurate understanding of the
particular disorder as a whole and not only on its genetic and clin-
ical aspects (Barkovich et al., 2012). Advances of neuroimaging
and genetic tools have resulted in an unprecedented profusion
of information on gene mutations and structural abnormalities
underlying a particular syndrome. It has become clear that muta-
tions of a gene are not necessarily linked to a single syndrome
and that clinical definition encompasses a variety of underlying
biological processes. Mutations of different genes can similarly
affect a particular cellular process or different processes down-
stream in their molecular pathway (e.g., LIS1 and doublecortin in
microtubule function). Hence, the intricacy of these syndromes
reflects the complex interaction between genetic variations, de
novo mutations, early brain developmental disruptions and late
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secondary perturbations, i.e., the multiple-hit hypothesis. A bet-
ter understanding of these processes, in terms of the pathways
and pathomechanisms affecting the normal developmental pro-
gram and its modulation by environmental/epigenetic factors, is
a major requirement for optimal clinical classification and diag-
nosis. Experimental models are still required to advance in this
direction.
The mitotoxic agent methylazoxymethanol (MAM) has been
traditionally used to induce developmental brain dysfunction
in rodents (Cattabeni and Di Luca, 1997; Colacitti et al., 1999;
Battaglia et al., 2003). In this model, MAM is injected into
pregnant animals; it crosses the placental barrier and pro-
duces a dose-dependent action on the embryonic brain. MAM
exposure at different embryonic stages affects actively divid-
ing neuroepithelial cells during S-phase (Matsumoto et al.,
1972; Johnston and Coyle, 1979; Cattaneo et al., 1995). At
E15, MAM results in a range of cortical malformations in
rats, including hippocampal heterotopias and dysplasia (Zhang
et al., 1995; Colacitti et al., 1999; Baraban et al., 2000). At E17,
offspring display milder hippocampal heterotopias with predom-
inant dyslamination and dysplasia in the entorhinal and pre-
frontal cortices (Gourevitch et al., 2004). MAM E15-treated rats
exhibit enhanced excitability and are used in epilepsy research
(Pitkänen et al., 2005). MAM E17-treated rats exhibit impair-
ment of pre-pulse inhibition and behavioral abnormalities rem-
iniscent of the positive symptoms of schizophrenia (Gourevitch
et al., 2004; O’Donnell, 2011). This large spectrum of his-
tological, behavioral and clinical effects highlights the useful-
ness of this model and suggests that it could be important to
exert a more rigid spatiotemporal control of mitotoxic agent
administration.
Here, we introduce a different model of cortical malfor-
mations in mice induced by single intra-ventricular injec-
tion of MAM to embryos in utero. This approach permits a
better dosage, as well as temporal and spatial control as com-
pared to the transplacental approximation. To focus on hip-
pocampal developmental malformations potentially revelant for
epilepsy research, we used embryonic stages E14–E15 to target
the peak of hippocampal pyramidal cell neurogenesis (Grove
and Tole, 1999; Khalaf-Nazzal and Francis, 2013). We char-
acterized this model using combined histological and electro-
physiological approaches to focus on the presence of ectopic
cell groups and aberrant circuits in the neocortex and hip-
pocampus and possible alterations of the excitatory/inhibitory
balance. In addition, we compared the histo- and physio-
pathological features of our model with a genetic epilepsy-prone
model of hippocampal malformation, the doublecortin (Dcx)
knockout mouse (Nosten-Bertrand et al., 2008; Bazelot et al.,
2012).
MATERIALS AND METHODS
All experimental protocols and procedures met current Spanish
legislation (R.D. 1201/2005 and L.32/2007), the European
Communities Council Directive of 24 November 1986
(86/609/EEC) and European Union Council Guidelines of
2003 (2003/65/CE) for animal research and they were approved
by the ethics committee of the Instituto Cajal, CSIC.
ANIMALS
Pregnant C57BL6/6J mice were obtained from the animal facility
of the Instituto Cajal. The day of detection of the vaginal plug
was considered embryonic day 0 (E0). Embryos were injected
intraventricularly with either MAM or saline (see below) and
examined postnatally at P17 or adulthood (2–6 months). We
included non-manipulated standardly bred mice as a control
group. Doublecortin knockout mice (Dcx-KO) on the C57BL/6J
background and their wild-type littermates were used for addi-
tional anatomical and electrophysiological studies. Dcx-KO mice
(Kappeler et al., 2006) were obtained from the animal facility
of the Université Pierre et Marie Curie in Paris, and the CDTA,
Orleans, France, genotyped and maintained at the quarantine of
the animal facility of the Instituto Cajal.
INTRAVENTRICULAR IN UTERO INJECTIONS
E14–E15 pregnant mice were anesthetized with isoflurane and
their uterine horns were exposed through the abdominal wall.
Body temperature was kept constant at 37◦C with a heating blan-
ket. A volume of 0.7–3µl of MAM (several concentrations, see
Results) or saline (NaCl 0.9%) was injected in the lateral ven-
tricle of several embryos using a glass pipette (1.2mm outer
diameter, 0.69mm inner diameter, Harvard Apparatus) coupled
to an automatic microinjector (VisualSonics Inc, Canada) using
standard approaches (Walantus et al., 2007). In initial attempts,
we used ultrasound control for guiding injections (VeVo 770,
VisualSonics Inc, Canada), but we found it was not required for
embryos older than E14. Fast green (Sigma) was added at 0.05%
to visually confirm injection. Non-injected embryos were marked
with DiI (1:5 in DMSO, Invitrogen) at either the hindpaw or
the thigh. The uterine horns were set back into the abdomen,
which was filled with warm physiological saline, and the abdom-
inal muscle and skin were closed with silk sutures. Immediately
after surgery, pregnant mice received a subcutaneous injection
of the antibiotic enrofloxacine (Baytril, 5mg/Kg, Bayer) and an
intraperitoneal injection of the analgesic meloxicam (Metacam,
0.3mg/Kg, Boehringer Ingelheim).
Mice were examined at P3 to look for DiI marks in order to
classify them as injected (MAMor saline) or non-injected animals
(i.e., littermates of injected embryos that were not manipulated
but shared the uterine environment). These non-injected ani-
mals were discarded for this study. We included non-manipulated
mice, i.e., standardly bred mice, as a control group. Littermates of
same sex were housed together at weaning. Mice were maintained
under controlled conditions (temperature of 22 ± 2◦C and 12:12
light–dark cycle, lights on at 7 am) with free access to food and
water.
HISTOLOGICAL STUDIES
Histological studies were conducted in juvenile animals (P17)
and in adult mice (2–6 months) recorded electrophysiologically.
Mice were perfused intracardially with 5–10ml of PBS and 0.2%
heparin followed by 10–30ml of 4% paraformaldehyde in PBS,
pH 7.4. Brains were then removed, weighted and stored in the
fixative solution overnight. Coronal sections of 50µm were cut
using a vibratome. To facilitate localization and comparison with
other studies we refer to comparable Bregma levels in terms of
Frontiers in Systems Neuroscience www.frontiersin.org April 2014 | Volume 8 | Article 50 | 2
Cid et al. Intraventricular MAM model of cortical malformations
stereotaxic coordinates of the Paxinos’ atlas of adult mice (in
mm). One section every three, covering from 0mm to −4mm
in anteroposterior Bregma levels, were processed for histological
analyses either by toluidine blue staining (0.05%) or by immuno-
labeling of the neuronal protein NeuN. For NeuN immunos-
taining, free-floating sections were treated with 1% H2O2 for
20min, followed by washes in 0.1M PBS and incubation in 10%
fetal bovine serum (FBS) and 0.25% Triton for 1 h. Subsequently,
sections were incubated with an anti-NeuN mouse antibody
(1:1000, Bachem) overnight at room temperature, washed and
incubated with a biotinylated anti-mouse IgG antibody (1:200,
Vector Laboratories) for 2 h. After PBS washes, the avidin-biotin-
peroxidase complex (1:100, Vector Laboratories) was applied for
1 h and finally processed by 0.05% diaminobenzidine tetrahy-
drochloride (Sigma) and 0.01% H2O2 under stereomicroscope
control. Sections were mounted on gelatin-coated slides, dehy-
drated and cover- slipped with DePex (Serva). Alterations in
cortical and hippocampal histoarchitecture were evaluated in
a stereomicroscope (S8APO, Leica ) and photographed with a
coupled DFC295 camera (Leica). They typically comprised sub-
cortical and cingular heterotopias, cortical dyslamination, corpus
callosal dysgenesis and hippocampal heterotopias (see below for
details on quantitative analysis).
IN VIVO ELECTROPHYSIOLOGY UNDER URETHANE
Adult mice (2–6 months) were anesthetized with urethane
(1.7 g/kg, i.p.) in two doses of 0.85 g/kg with a 20min interval and
immediately warmed with a heating blanket to avoid hypother-
mia. Anesthetized animals were fastened to the stereotaxic frame
and body temperature was kept constant at 37–38◦C. Small holes
of 1.5mm diameter were drilled above the left hippocampus
for recording spontaneous and evoked CA1 activity (anterio-
posterior AP: −2.2, mediolateral ML: 1.5) and the Schaffer col-
lateral afferent volley (AP: −1.7, ML: 1.5). An additional hole
was drilled to place the ipsilateral CA3 bipolar stimulating elec-
trode (AP: −1, ML: 0.7). Stimulation consisted of biphasic square
pulses of 0.2ms duration and amplitudes of 0.025–1mA every
5 s. Signals were referenced against a subcutaneous Ag/AgCl wire
placed in the neck. The position of the stimulation electrode was
optimized to obtain a maximal population spike response at the
CA1 pyramidal layer with the lowest stimulus strength at both
polarities.
For recording of local field potential (LFP) activity we used
linear arrays of multi-site silicon probes of 32 electrodes at
25µm vertical spacing (NeuroNexus Tech). They were posi-
tioned to record from all strata simultaneously, from the CA1
to the dentate gyrus and CA3. Hippocampal strata were iden-
tified using information from typical LFP events including:
(a) multi-unit activity to identify the CA1–CA3 stratum pyra-
midale and the granule cell layer of the dentate gyrus, (b) rip-
ple events to identify CA1 cell layer; (c) sharp-wave events to
define the CA1 stratum radiatum, (d) the current source den-
sity signal (second spatial derivative of LFP interspaced 25µm)
of CA1 response to ipsilateral CA3 stimulation, and (e) the
spatial distribution of theta oscillations (4–12Hz) and gamma
activity (20–90Hz), which, together with the previous informa-
tion, allowed us to identify the stratum lacunosum moleculare
and the molecular layer of the dentate gyrus. Layer identifi-
cation was confirmed with post-hoc histological analysis of the
probe track. Extracellular signals were preamplified (4x gain) and
recorded with a 32-channel AC amplifier (Multichannel Systems,
model USB-ME32-FAI-System; Germany), further amplified by
100, filtered by analog means at 1Hz to 5 kHz, and sampled
at 20 kHz/channel with 12 bit precision. Evoked field postsy-
naptic potentials and afferent volleys were recorded in the CA1
stratum radiatum in response to ipsilateral CA3 stimulation.
Paired-pulse protocols were used to test for facilitation (using
stimulation intensities of 40% of the maximal response) and
inhibition (using maximal stimulation intensities) of the sec-
ond response at inter-pulse intervals of 25, 50, 75, 100, 125, and
150ms.
CHRONIC VIDEO-EEG RECORDINGS
In order to look for signs of epilepsy and to further study
the presence of EEG rhythmopathies in MAM-treated mice
we used long-term video-EEG recording of freely moving ani-
mals. To this purpose, mice (2–6 months) were implanted with
two cortical screws (1mm diameter) above the motor cortex
(AP +1.5mm, L 1.5mm) of both hemispheres under isofluorane
anesthesia (1.5% in oxygen 30%). Temperature and physiolog-
ical variables were continuously monitored with an oximeter
(MouseOX, Starr Life Sci, USA). A third screw served as refer-
ence at the occipital region (AP −6mm, ML 0mm). All screws
were placed epidurally to avoid damaging the brain. The con-
struct was fixed to the skull with dental cement and anchored
to two additional screws implanted for stability purpose. Mice
were submitted to dietary care and continuous hydration over
the next 1–2 days after surgery. One week after recovery and
habituation to the recording cage, the EEG and video sig-
nals were monitored in sessions of 3–8 h every day, during
approximately 2–3 weeks per animal. Several blocks of con-
tinuous video-EEG (up to 48 h) were also recorded over the
weeks.
For video-EEG recordings, we used a wireless 1-channel EEG
recording unit (Epoch, Ripple, USA). The unit consist of a
transistor (R01057-6) wired to two copper electrodes connected
to the implanted screws, and a receptor enclosure (50 × 27 ×
31 cm) with BNC connectors to output signals in the ±5V
range with 1–500Hz bandpass digital filter. We recorded from
the right and the left electrodes in different sessions. No dif-
ferences were apparent and data was pooled. The signal was
subsequently amplified x5, digitalized (Digidata 1200B, Axon
Instruments) and recorded at sampling rate of 2000Hz. For
simultaneous video recording, we used a webcam (Hercules HD
Exchange 720p, 30 frames/sec at 320 × 240 resolution) installed
at the top of the receptor cage. The video and the EEG sig-
nals were synchronized using an in-house made Arduino-based
device (http://www.arduino.cc/) programmed to: (a) control a
red LED that lights every 8 s (duration 1 s) on the webcam
field (not visible to the animal), (b) send a synchronizing sig-
nal (square pulses of 1 s duration at 8 s interval) to the digi-
tizer card. Synchronized video-EEG data were obtained using a
dedicated graphic interface designed in Matlab (The Math Works
Inc., USA).
Frontiers in Systems Neuroscience www.frontiersin.org April 2014 | Volume 8 | Article 50 | 3
Cid et al. Intraventricular MAM model of cortical malformations
SYSTEMIC INJECTION OF PILOCARPINE AND PENTYLENETETRAZOL
In order to test for pharmacological threshold for seizure
induction we used intraperitoneal injection of lithium-chloride
(423mg/kg, Sigma) followed by pilocarpine hydrochloride
(100mg/kg) about 24 h after lithium injection under EEG-control
in a group of implanted mice. We also used pentylenetetrazole
(90mg/kg; Sigma Aldrich) in a different cohort of animals to test
for different pharmacological sensitivity. Progression to seizure
activity was monitored both clinically and electrographically. We
characterized different features of seizure activity to score animal
response to convulsants: (a) the latency to the first EEG seizure,
(b) duration of the first EEG seizure, (c) latency to the onset of




Coronal sections (50µm) stained with toluidine blue or NeuN
immunolabeling were evaluated to identify and quantify cortical
and hippocampal malformations. In order to standardize analy-
sis (comparable age and brain weight) histological quantification
was performed only in P17 mice. To facilitate identification of
anatomical planes, all references to anteroposterior Bregma levels
at P17 are inferred from equivalent sections shown in the Paxinos’
atlas of adult mice and indicated in millimeters. One every three
sections from both hemispheres (covering from 0 to −4mm in
anteroposterior Bregma levels) were analyzed for cingular and
subcortical heterotopias. The total anteroposterior extension of
each heterotopia was estimated (AP extension) and a midpoint
was defined at the half distance from the first and the last sec-
tions where it appeared. When several clusters were encountered,
they were considered as part of a single heterotopic complex for
quantitation purposes. To evaluate potential hypomorphism of
the corpus callosum, one every three sections were examined to
determine the most caudal coordinate where the corpus callosum
was present.
To quantify hippocampal malformations, we used sections
containing the dorsal hippocampus, typically between −1
and −2.5mm from Bregma. The volume of the dorsal hippocam-
pus was estimated by the Cavalieri method from one every three
coronal sections using the ImageJ software (NIH, USA).To char-
acterize CA3 dyslamination we estimated the thickness of the
entire stratum pyramidale, including the two layers found in
MAM-treated mice. The interlayer distance was estimated from
the midpoint of each layer. Measures were made at CA3b in
sections at about −2mm from Bregma. CA1 heterotopias were
characterized at their midpoint section. The mediolateral and
dorsoventral extensions of the heterotopia were calculated using
the ImageJ software. In cases of more than one heterotopia per
animal these were analyzed independently. The distance from the
heterotopia to CA1 pyramidal cell layer was estimated from the
centroid of the heterotopic cluster.
In vivo anesthetized data
Evoked postsynaptic potentials (fEPSP) and presynaptic afferent
volleys (AV) were analyzed with routines written in Matlab using
signals from the stratum radiatum. To build the input/output
curve, we calculated the mean amplitude and slope of the fEPSP
in response to 8 stimuli at growing intensities (from 25 to 900µA)
using the initial falling phase to avoid contamination with the
population spike. Paired-pulse facilitation and inhibition (eval-
uated at the stratum pyramidale) were estimated using the ratio
between the second and the first response, calculated as described
for input/output curves.
To quantify potential hippocampal rhythmopathies in MAM-
treated and Dcx-KO animals we performed spectral analysis of
LFP signals during periods of theta (4–10Hz) and large-irregular
activity, typically present under urethane (Clement et al., 2008).
For theta analysis, we selected epochs of continuous activity last-
ing 1–2min. LFP signals around the stratum lacunosum molecu-
lare were Fourier-transformed at 0.5Hz resolution and the theta
peak frequency was defined as themean power peak of the average
spectrum in the 4–10Hz band. We chose non-overlapping data
segments (1 s) with clear theta activity, as evaluated by spectral
criteria. The theta frequency peak, as well as theta and gamma
power, was estimated at a resolution of 1-Hz. The spectral power
was given in decibels (10.log10) and calculated using a Hamming
window and the Fast Fourier Transform. Theta and gamma power
were defined from the spectral area in the 4–10Hz and 30–90Hz
band, respectively. Spectral measurements were normalized by
the 1/f decay at the 500–1000Hz band.
To analyze ripple events, we chose LFP signals recorded at
the stratum pyramidale of CA1 during epochs of large-irregular
activity. We carefully selected sites with poor multi-unit activity
to avoid high-frequency contamination. Signals were band-pass
filtered between 100 and 600Hz using a forward-backward zero-
phase FIR filter of order 512 and frequency resolution of 10Hz.
To detect ripples, the band-pass filtered signal was subsequently
smoothed using a Savitzky-Golay (polynomial) filter and events
were detected by thresholding (>2.5 SD). Spectral analysis was
performed in windows of ±200ms centered at the detected event.
Time-frequency representations were obtained by applying the
multi-taper spectral estimation in sliding windows with 97.7%
overlap and a frequency resolution of 10Hz to 400ms windows
centered in ripple events. The power was estimated by averag-
ing time-frequency spectra around the detected event. Ripple
duration was evaluated by applying the Hilbert transform to the
100–600Hz filtered signal using a threshold at 1.6 SD. The ampli-
tude of the associated sharp-wave was estimated at the stratum
radiatum.
Chronic video-EEG data
Continuous video-EEG data were examined by an expert clini-
cal neurophysiologist (DML) to define well separated behavioral
states: (a) active awake, typically consisting of exploratory behav-
ior associated with dominant theta activity and (b) sleep, which
was subsequently categorized as periods of REM sleep and non-
REM slow-wave sleep (SWS) according to EEG information. In
addition, continuous video-EEG data were examined for signs
of epileptiform activities consistent of large amplitude interictal-
like spikes, spike and wave components and seizure-like events.
Quantitative spectral analysis was performed in the 1–50Hz range
using non-overlapping data segments of 5 s, selected from pre-
defined behavioral epochs as defined above, at 1Hz resolution.
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To analyze spindle activity, epochs of SWS were band-pass fil-
tered (7–16Hz) with a forward-backward zero-phase FIR filter of
order 512, and frequency resolution of 0.5Hz. The signal was then
smoothed (Savitzky-Golay) and candidate events were detected
by thresholding (>2.5 SD). Spindles were characterized by: (a)
their duration, defined from the Hilbert transformation of the
filtered signal at 1.6 SD threshold, (b) the spindle power in the
10–16Hz band, estimated by averaging time-frequency spectra
around each detected event, and (c) the inter-spindle interval.
Statistical analysis
Data are expressed as mean ± SD. Statistical analyses were
performed using SPSS 18.0 for Windows. Normality was con-
firmed using the Shapiro-Wilk test. Histological comparisons
were performed by One-Way ANOVA factor “MAM” followed
by two-tailed Student t-test. Electrophysiological fEPSP responses
(input/output curves and paired-pulses) were analyzed by One-
Way ANOVA factor “AV amplitude” or “Stim intensity.” The
spatial distribution of spectral features (power, frequency) of
brain rhythms and events (theta, gamma and ripples) were ana-
lyzed with One-Way ANOVA factor “distance.” Event (ripple and
spindles) features (duration, rate, spectral power and dominant
frequency) were evaluated with two-tailed Student t-tests. In all
cases we use p = 0.05 as significance level. Significance level was
corrected for multiple comparisons whenever appropriate.
RESULTS
A DIRECT INTRAVENTRICULAR APPROACH TO EMBRYONIC MAM
INJECTION IN UTERO
In order to gain a better temporal and spatial control of MAM
injection compared to the transplacental approach, we established
an intraventricular embryonic injection method (Figure 1A).
Embryos were injected at E14 (n = 20) and E15 (n = 26) with
different MAM concentrations (see below) together with 0.05%
Fast Green for visual confirmation (Figure 1B). First, we noted
there was a maximal MAM dose compatible with healthy preg-
nancy, and found that accumulated concentrations higher than
5400 nmol (corresponding to 23mg/kg) were more likely to
induce spontaneous abortion and maternal death. This is con-
sistent with the transplacental approximation, where equivalent
doses are used for intraperitoneal injections of pregnant mice
(25mg/kg). In pilot experiments we also defined the total volume
per embryo and found more reliable results with 0.7µl for E14
embryos and 1.5–3µl for E15.
We tested a range of MAM concentrations for injections at
E14 and E15 to induce developmental malformations in off-
spring, as examined at P17 (Figures 1C,D). Based on preliminary
tests, we used concentrations of 0.3, 140, and 210 nmol for MAM
injections at E14. We found more consistent malformations at
210 nmol MAM, and no obvious effect at 0.3 nmol. For injections
at E15, we used 6, 600, and 900 nmol MAM and found devel-
opmental malformations in offspring for 600 and 900 nmol, and
no obvious effect at 6 nmol. A major feature of developmental
cortical malformations is the presence of microcephalia, which
can be found both in patients and in animal models (Guerrini
et al., 2008). Similar to transplacental MAM,mouse weight at P17
was rarely affected (Figure 1C) but brain weights were smaller
FIGURE 1 | Experimental approaches and control experiments. (A)
Different doses of methylazoxymethanol (MAM) or saline were injected
intraventricularly in mouse embryos at E14 and E15 in utero using glass
pipettes. The ultrasound image shows one embryo with the glass pipette
visible on the left. (B) Fast green was used to visually confirm injection.
(C) Dependence of the mouse weight at P17 on different treatments. NM,
non-manipulated mice. S, saline-injected mice. Data is presented as
mean ± SD. Number of animals are indicated at each column. (D)
Dependence of the brain weight at P17 on different treatments, with
number of animals indicated. In (C,D), ∗∗ (∗∗∗) stands for p < 0.001
(p < 0.0005) in comparison with NM. (E) Saline-injected mice showed no
major differences with non-manipulated standardly bred mice.
Representative coronal sections equivalent to −2.7 to −3.0mm posterior
(AP, in mm) to Bregma were used to evaluate the cingulum. (F) Coronal
sections equivalent to −1 to −2.5mm from Bregma were used to evaluate
the dorsal hippocampus and the callosal bundle. Scale bars correspond to
300µm.
in mice injected at E14 with 210 nmol MAM and at E15 with
900 nmolMAM vs. non-manipulated normally bred mice (n = 7;
Figure 1D). Giving a maximal accumulated dose of 5400 nmol
per pregnant mouse, we were limited to 6 embryos when MAM
was injected at E15 and had no limitation (up to 25 embryos) for
E14 injections.
The sham effect was evaluated by injecting E14 and E15
embryos with saline (0.9% NaCl, n = 20). We found no
difference with non-manipulated normally bred mice either
for body or brain weights (Figures 1C,D, black boxes; no
significant differences) and no developmental malformations
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when examined histologically, either in the cingulum and neo-
cortex (Figure 1E) or in the dorsal hippocampus (Figure 1F). We
therefore pooled saline-injected and non-manipulated mice in a
single control group.
DEVELOPMENTAL NEOCORTICAL MALFORMATIONS IN
MAM-INJECTED MICE
Quantitative histological analysis was performed from coronal
brain sections obtained from control and MAM-injected mice
at P17, but similar alterations were observed in adult animals of
different ages (from 2 to 6 months). A range of developmental
cortical malformations was present in both E14 and E15 MAM-
injected animals. In contrast to transplacental MAM that exhibits
less systematic spatial distribution of cortical heterotopias, we
found precise and consistent periventricular heterotopic clusters
at the cingulum (Figure 2A, red and blue arrows), similar to
the cytosine arabinoside (Ara-C) model and BXD29-Tlr4lps-2J/J
mutants (Ono-Yagi et al., 2000; Rosen et al., 2013). These cingular
heterotopias were located under the retrosplenial cortex, typically
centered between −3 and −1.5mm posterior to Bregma, having
an anteroposterior extension of about 1–2mm (Figure 2B). They
were present in 100% of E14- and E15-injected mice, although
they were usually larger in the last group.
In addition, subcortical heterotopic clusters were sometimes
observed at more lateral positions (under MPtA, LPtA, S1Tr,
V2M, V1 regions of the cortex as abbreviated in Paxinos’
atlas). They were evident either bulging into the white matter
(Figure 2A′, red arrow at E14) or as well-differentiated frag-
mentations (Figure 2A′, blue arrows at E15). These subcortical
heterotopias were more frequent and larger in E15- (73% injected
mice) vs. E14-injected mice (56%) (Figure 2C). In all cases,
these heterotopias were associated with cortical dyslamination
and overmigration, mainly affecting layer II all along the cor-
tex (Figure 2A′′). Similar structural alterations were confirmed in
adult mice (2–6 months, not shown). Therefore, intraventricular-
injection of MAM at E14 and E15 resulted in cortical mal-
formations resembling periventricular/subcortical heterotopias
observed in the Ara-C and transplacental MAM model (Colacitti
et al., 1998; Ono-Yagi et al., 2000; Tschuluun et al., 2011).
CORPUS CALLOSUM HYPOMORPHISM IN MAM-INJECTED MICE
A number of malformations of cortical development are com-
monly associated with corpus callosum dysgenesis, both in
humans and in animal models (Raybaud, 2010). Similarly, in
MAM-injected animals we noted the absence of corpus callo-
sum in coronal sections at caudal levels (Figure 2D), suggesting
an impaired commissural genesis. This shortening of corpus cal-
losum in the anteroposterior axis was evident in 90% of E14-
and 100% of E15-injected mice, with stronger dose-dependent
reduction in E14 MAM-injected animals (Figure 2E, blue bars).
In adult mice (2–6 months) we confirmed similar signs of corpus
callosum hypomorphism (E14: 81% mice, E15: 100% mice, not
shown).
HIPPOCAMPAL HETEROTOPIAS
Hippocampal abnormalities are present in some types of malfor-
mations of cortical development in human (Kuchukhidze et al.,
2010). In intraventricularly MAM-injected mice, we found hip-
pocampal lamination defects and heterotopias (Figure 3A), con-
sisting of a drastic loss of CA3c (arrowheads) and a double CA3
cell layer (arrows), similar to mice carrying mutations of Dcx
(Nosten-Bertrand et al., 2008). The CA3 double layer typically
appeared from −1 to −3mm in the anteroposterior axis. The
inter-layer distance in CA3 was not different between E14 and
E15-injected animals (Figure 3B). Such alterations in CA3 were
observed in all MAM-injected mice either at P17 or adulthood.
Interestingly, segregation of CA3 stratum pyramidale into two
layers did not affect the total thickness of the cell body layer
(Figure 3B). Reduced hippocampal volumes were present in all
MAM-injected animals, but the effect was more severe in mice
injected at E14, than at E15 (Figure 3C).
A major characteristic of the transplacental MAM model
is the presence of heterotopias in the pyramidal layer of CA1
(Chevassus-Au-Louis et al., 1998c; Baraban et al., 2000). In
our model, these heterotopic clusters were observed in most
mice injected at E15 (71% for 600 nmol MAM, and 75% for
900 nmol MAM), and were less frequent for MAM injections
at E14 (50% for 210 nmol MAM, none for 140 nmol MAM)
(Figure 3D). However, in utero MAM-injections at E14 had a
more dramatic effect on CA1 dyslamination than injections at
E15, leading to a more diffuse and less well organized pyrami-
dal cell layer (Figures 3A,D). CA1 heterotopias were confirmed
in adult MAM-injected mice, with similar frequency of hetero-
topias (E15–900 nmol: 83% mice, E14–210 nmol: 38% mice).
Interestingly, we also found striking differences between mice
injected at E14 and E15 with respect to the position of the CA1
heterotopia, as examined at P17 and adulthood. Mice injected
at E14 exhibited larger CA1 cell layer dispersion and heterotopic
clusters tended to accumulate below the pyramidal layer extend-
ing into the stratum radiatum (Figure 3E, red dots). In contrast,
mice injected at E15 had a more clearly organized CA1 region and
focal heterotopias were often found, but not always, over the CA1
pyramidal cell layer in the stratum oriens (Figure 3E, blue aster-
isks). Themean distance from the CA1 cell layer was 142 ± 48µm
in E14 and 128 ± 59µm in E15 MAM-injected mice. In general,
the extension of CA1 heterotopias was larger for E15 vs. E14, both
in the mediolateral and dorsoventral directions (Figure 3F).
MAM-INJECTED MICE EXHIBIT HIGHER HIPPOCAMPAL EXCITABILITY
The heterotopias observed in CA1 and the presence of the CA3
double layer open the possibility of formation of aberrant circuits
in the hippocampus of these mice, as described in the transpla-
cental MAM approximation (Chevassus-Au-Louis et al., 1998b)
and in Dcx-KO mice (Bazelot et al., 2012). While dysplastic clus-
ters are not necessarily epileptogenic, indications suggest that it
is the interaction between heterotopias and surrounding regions
that potentially underlies excitability (Kobayashi et al., 2006;
Ackman et al., 2009; Schwartzkroin andWenzel, 2012). Therefore,
we studied the electrophysiological properties of the dorsal hip-
pocampus of MAM—injected mice (E14, n = 19) in compar-
ison with epilepsy-prone Dcx-KO mice (n = 13) with similar
structural alterations in CA3 (Nosten-Bertrand et al., 2008) and
control animals (non-manipulated and wild-type n = 21; saline-
injected n = 12). Data from wild-type littermates of Dcx-KO
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FIGURE 2 | Developmental neocortical malformations observed at P17
in MAM-injected mice. (A) Cingular heterotopias were typically present
in MAM-injected mice (arrows) at anteroposterior (AP, in mm) locations of
between −3 and −2.7mm from Bregma equivalent sections. Boxes in
superficial cortical layers are expanded on the right. Scale bars correspond
to 300µm. (A’) Subcortical heterotopic clusters were observed at
different lateral positions. Arrows indicate individual heterotopias. Scale
bars correspond to 300µm. (A′′) Cortical dyslamination and overmigration
were found to mainly affect layer II throughout the cortex. Images show
an enlarged section as indicated by color boxes in (A). Scale bars
correspond to 300µm. (B) Relationship between the cingular heterotopic
midpoint and the anteroposterior (AP) extension, for mice injected at E14
(red) and E15 (blue). ∗∗ stands for p < 0.001. (C) Relationship between
the subcortical heterotopic midpoint and the AP extension. ∗ stands for
p < 0.05. (D) Corpus callosum hypomorphism was evaluated in coronal
sections at different AP levels from Bregma (in mm). Absence of the
callosal bundle was found at different levels in MAM-injected mice
(arrows). Scale bars correspond to 500µm. (E) Dose dependent effect of
MAM on the caudal limit of the callosal bundle. Numbers indicate the
animals used for quantification. ∗∗ (∗∗∗) stands for p < 0.001 (p < 0.0005)
in comparison with control animals. The control group (n = 4) includes 2
non-manipulated and 2 saline-treated (sham) mice.
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FIGURE 3 | Hippocampal heterotopias. (A) Lamination defects, including
double CA3 layer (arrows) and loss of CA3c (arrowheads) were evident at
P17 and at adulthood (see Figure 6) in the dorsal hippocampus of
MAM-injected mice. Scale bars correspond to 300µm. AP, equivalent
anteroposterior coordinate from Bregma (in mm). (B) Group data on
interlayer distance and total CA3 thickness. Number of animals used for
quantification is indicated. (C) Dose dependent effect of MAM in the
volume of the dorsal hippocampus. (D) CA1 heterotopias were frequently
found in MAM-injected mice. Images show NeuN immunostaining at P17.
Scale bars correspond to 300µm. (E) Position of the CA1 heterotopia in
mice injected at E14 and E15 in the anteroposterior (AP) direction (x-axis)
and with reference to CA1 stratum pyramidale (y-axis). In spite of
variability, note different location of the center of the heterotopic clusters
around the stratum pyramidale in E14 vs. E15. The anteroposterior linear
trend of the alveus and the hippocampal fissure is shown for reference as
mean (thick line) ± SD (discontinuous lines). (F) Group data of the CA1
heterotopic extension in the mediolateral (ML) and dorsoventral (DV)
direction. Number of animals are indicated. The control group (n = 4)
includes 2 non-manipulated and 2 saline-treated (sham) mice. ∗p < 0.05,
∗∗p < 0.01 and ∗∗∗p < 0.001.
mice were similar to control mice data and were pooled in a
control group. We focused on E14 MAM-injected animals since
these exhibited more extensive hippocampal dyslamination (for
E15 MAM-injected mice see below).
Multi-site silicon probe recordings were obtained in brains
of urethane-anesthetized mice to examine input/output (IO)
responses of CA1 to ipsilateral CA3 stimulation, as a proxy for
hippocampal excitability. We targeted the dorsal hippocampus
both at rostral (−1.7mm from Bregma) and caudal (−2.2mm)
coordinates to examine the presynaptic CA3 afferent volley (AV,
Figure 4A) and the orthodromic postsynaptic response, respec-
tively (Figure 4B). Recording sites at the strata pyramidale and
radiatum were selected to monitor both the population spike and
the fEPSP.
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FIGURE 4 | Enhanced hippocampal excitability in MAM-injected mice.
(A) Multi-site silicon probes were used to target different layers of the dorsal
hippocampus of urethane-anesthetized control and E14 MAM-injected mice.
We also included doublecortin knockouts (Dcx-KO) for comparison. We
recorded both the presynaptic CA3 afferent volley (AV) and the orthodromic
postsynaptic response at about −1.7mm from Bregma (AP) and 1.5mm
lateral (L). The red discontinuous line marks the probe track position. Scale
bars correspond to 500µm. We chose channels at the stratum pyramidale
(pyr) and radiatum (rad), and used different stimulation intensities to evaluate
responses both subthreshold (left) and suprathreshold (right) to action
potential activation. (B) Recordings at more caudal coordinates did not show
the AV response and were used to validate orthodromic responses. Scale
bars correspond to 500µm. (C) Relationship between the amplitude of the
field excitatory potential (fEPSP) and stimulation intensity in the three
experimental groups. Data from n = 11 control (8 non-manipulated, 3 saline
injected), n = 6 MAM and n = 7 Dcx-KO. (C′) Relationship between the
amplitude of the afferent volley (AV) and stimulation intensity. (C′′)
Input/output curves suggest enhanced excitability in MAM-treated and
Dcx-KO mice, as compared to control. Data shown in (C′,C′′) are from n = 6
control (4 non-manipulated, 2 saline-injected), n = 6 MAM and n = 3 Dcx-KO.
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fEPSP responses recorded at more caudal coordinates sug-
gested stronger excitability of MAM-E14 injected mice when
compared with both control and Dcx-KO (Figure 4C). Thus,
the minimal current to induce a population spike was lower in
MAM-E14 (193 ± 20µA) vs. control (264 ± 23µA, t = −6.33,
p < 0.0001) and Dcx-KO mice (325 ± 61µA, t = −5.06, p =
0.0004). These differences could be related to different excitabil-
ity of the CA1 pyramidal cells themselves or to the different
recruitment of presynaptic axons. We therefore examined the
presynaptic AV response, which suggested poorer recruitment
in Dcx-KO mice when compared with both control and MAM
E14 injected animals (Figure 4C′), probably due to large disper-
sion of bilayer CA3 in Dcx-KO at the stimulation coordinate.
As a result, IO curves from Dcx-KO and MAM E14-injected
mice overlapped indicating stronger activation than in control
mice (Figure 4C′′). We also used paired-pulse (PP) stimulation
protocols to monitor for PP-inhibition, as a measurement of
GABAergic inhibitory function, and PP-facilitation, as a mea-
sure of presynaptic efficacy, and found no differences between
groups (Supplementary Figure 1). In spite of these similarities,
data from IO responses suggest that MAM E14-injected mice
exhibit higher hippocampal excitability, similar to Dcx-KO ani-
mals which have comparable structural malformations.
HIPPOCAMPAL RHYTHMOPATHIES IN MAM-INJECTED MICE
We then looked at potential alterations of hippocampal natural
rhythms, recorded under urethane, i.e., theta (4–6Hz), gamma
(30–90Hz) and high-frequency oscillations in the form of ripples
(100–250Hz). Theta oscillations were evaluated using recording
sites at all hippocampal layers from CA1 stratum oriens to the
molecular layer of the dentate gyrus (Figure 5A). Theta cycles in
MAM-E14 and Dcx-KO exhibited the characteristic phase rever-
sal between sites at the stratum lacunosum moleculare and the
CA1 stratum pyramidale, as described in normal mice (Buzsáki
et al., 2003). The power spectra of LFP signals recorded at the
stratum lacunosummoleculare were similar for all groups, with a
dominant peak at the theta frequency and spectral components at
the gamma band (Figure 5B). However, we noted reduced theta
power around the stratum lacunosum moleculare and into CA1
(defined as the area in the 4–10Hz band) in MAM E14 [F(1, 7) =
39.89, p < 0.001] but not in Dcx-KO mice [F(1, 7) = 2.92, p =
0.0905] when compared to control mice (Figure 5C). Similarly,
decreased gamma activity (30–90Hz) was evident in MAM E14
[F(1, 7) = 89.44, p < 0.001] and Dcx-KO mice [F(1, 7) = 9.01,
p = 0.0033; Figure 5C′]. These differences persisted after cor-
rection for 1/f noise as estimated from the 500–1000Hz band
(Figure 5B), to exclude potential differences in the electrode-
tissue interface. However, when the theta and gamma band were
normalized by the delta band, group differences vanished and no
differences were confirmed in the local current source density sig-
nal (Table 1), suggesting that there was a non-specific reduction
of the oscillatory power in all these bands.
We also looked at potential distortion of high-frequency oscil-
lations (HFOs) in E14 MAM-injected mice, as HFOs are used as
marker of epileptogenesis (Jefferys et al., 2012). To this purpose
we focused on episodes of large-irregular activity to detect rip-
ples (100–250Hz) around the stratum pyramidale in association
with sharp-waves at the radiatum of CA1 (Figure 5D). Sharp-
wave ripple events were similarly present in all groups, in terms
of rate of occurrence (control vs. MAM E14, t = −0.25, p =
0.8022; control vs. Dcx-KO, t = −1.38, p = 0.1687) and dura-
tion (Figure 5E). Similar to theta and gamma activity, the ripple
power was decreased both in MAM E14 and Dcx-KO mice when
compared to controls (Figure 5E). The sharp-wave amplitude was
also smaller in these groups (Figure 5F).
E15 MAM-injected mice were also examined (n = 11,
Supplementary Figure 2) and showed a similar trend,
though differences were weaker than those recorded in E14
MAM-injected animals. Thus, MAM-injected mice, similar to
Dcx-KO, showed hippocampal rhythmopathies reflected as a
non-specific reduction of the oscillatory power of all frequency
bands.
NO SIGNS OF EPILEPTOGENICITY IN MAM-INJECTED MICE EXAMINED
UNDER URETHANE
We specifically checked for signs of epilepsy in MAM-injected
mice under urethane, as described in a proportion of non-
anesthetized Dcx-KO animals (Nosten-Bertrand et al., 2008)
and in transplacental MAM models (Chevassus-Au-Louis et al.,
1998a). Surprisingly, we found no clear epileptiform events in any
of the recorded animals under urethane.
We wondered whether epileptiform activity was more likely
to be restricted to heterotopic clusters. Therefore, we separately
examined cases where the electrode penetration passed through
the CA1 heterotopia in a mouse injected at E14 (Figure 6A)
and one injected at E15 (Figure 6B). We found similar LFP
profiles in these animals as those previously described for elec-
trode penetration not targeting the heterotopia (Figures 6A′,B′),
suggesting that signals are strongly dominated by volume con-
duction. No evidence of epileptiform events were detected
in these recordings, which showed roughly similar spectral
features as compared with the corresponding MAM-injected
group (Figures 6A′′,B′′). In n = 3 mice (n = 2 MAM-E14, n = 1
MAM-E15), the recording probe penetrated the CA3 double
layer and these cases were analyzed separately (Figure 6C). We
found no evidence of epileptiform activities in these cases.
Differences were only found in the spatial distribution of
multi-unit activity (MUA) which gave two peaks for MAM-
treated mice, consistent with the position of the double layer
(Figure 6C′).
Therefore, MAM-injected mice showed no evidence of
epileptogenicity under urethane anesthesia. However, since
they exhibited a non-specific reduction of oscillatory power
of theta, gamma and ripple activity, similar to Dcx-KO,
and because a proportion of Dcx-KO mice exhibited hyper-
excitability and interictal spikes when recorded chronically
(Nosten-Bertrand et al., 2008), we wondered whether urethane
could be masking epileptiform events in E14 MAM-injected
mice.
CHRONIC VIDEO-EEG RECORDINGS REVEAL ABNORMAL SPINDLE
ACTIVITY BUT NOT EPILEPTIFORM EVENTS
Both control (n = 7) and E14 MAM-injected mice (n = 7) were
implanted with epidural screws for EEG recordings coupled to
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FIGURE 5 | Hippocampal rhythmopathies in MAM-injected mice. (A)
Local field potentials (LFPs) recorded from different hippocampal layers
using multi-site silicon probes were examined to look at differences of
theta oscillations under urethane. Note increase of theta activity at the
stratum lacunosum moleculare. Or, stratum oriens; pyr, stratum
pyramidale; rad, stratum radiatum; slm, stratun lacunosum moleculare;
mol, stratum moleculare. (B) Mean power spectrum data from different
groups as recorded at the slm electrode exhibiting the stronger spectral
power. Discontinuous line represents 95% confidence interval. Note
deviation from 1/f noise in all cases, and dominant peaks at theta
(4–6Hz) and gamma (30–40Hz) frequencies. (C) Spatial distribution of the
normalized (1/f corrected) theta power area (4–10Hz) around the statrum
lacunosum moleculare (taken as reference). Inset plots group differences
of theta frequency peak. ∗ stands for p < 0.05 in comparison against
control. (C′) Spatial distribution of the gamma power area (30–90Hz)
around the slm (taken as reference). The inset plots group differences of
gamma frequency peak. Data shown in (B–C′) are from n = 10 control (7
non-manipulated, 3 saline-injected), n = 8 MAM, and n = 5 Dcx-KO. (D)
Potential differences of sharp-wave ripple events were evaluated using
recordings from the stratum oriens, pyramidale, and radiatum. Individual
events were detected (left) and their high-frequency spectrum
(100–300Hz) analyzed (right). High-frequency oscillations (ripples) at
100–150Hz were dominant around the stratum pyramidale. Ripple power
was strongly reduced in MAM-injected and Dcx-KO. (E) Group differences
of mean ripple power as detected at the stratum pyramidale. (F) Group
differences of sharp-wave amplitude as compared with control. Data
shown in (E,F) are from n = 15 (463 events) control (299 events from 10
non-manipulated; 163 events from 5 saline-injected), n = 5 (123 events)
MAM and n = 6 (217 events) Dcx-KO. ∗ (∗∗) stands for p < 0.05
(p < 0.01) in comparisons with control.
video imaging for behavioral and clinical evaluation. We first
focused on detecting signs of epilepsy during different behavioral
phases, including active exploration, quiet wakefulness and sleep,
recorded over several days.
We found no clear evidence of spontaneous epileptiform activ-
ity in anyMAM-injected animal examined, that exhibited crudely
similar EEG patterns compared with control mice (Figure 7A).
During active exploration, theta oscillations dominated EEG
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Table 1 | Spectral features of local field potentials and current source density signals in the theta (4–10Hz) and gamma (30–90Hz) frequency
bands.
Control (10) MAM E14 (9) t,p (df = 16) Dcx KO (7) t,p (df = 14)
LOCAL FIELD POTENTIALS (LFPs)
Power delta (1–4Hz) 80.43± 3.93 74.09± 4.82 3.1581, 0.057 77.53± 2.35 1.5119, 1.528
Power theta (4–12Hz) 91.86± 2.02 87.01± 3.50 3.8285, 0.013 88.67± 3.27 2.4193, 0.297
Power gamma (20–90Hz) 84.29± 3.40 79.44± 2.57 3.3873, 0.035 80.21± 2.80 2.3381, 0.347
Theta/Delta 1.14± 0.04 1.18± 0.05 −1.4772, 1.579 1.14± 0.02 0.0139, 9.891
Gamma/Delta 1.05± 0.03 1.08± 0.07 −1.1208, 2.780 1.03±0.02 0.8725, 3.977
Gamma/Theta 0.92± 0.02 0.91± 0.04 0.2038, 8.409 0.90± 0.01 1.2655, 2.264
Frequency peak theta 5.69± 0.30 6.05± 0.33 −2.4517, 0.253 5.64± 0.30 0.3145, 7.578
Frequency peak gamma 31.85± 7.61 36.18± 9.44 −1.1055, 2.844 26.48± 6.11 1.3821, 1.886
Power peak theta 86.03± 2.71 82.12± 3.45 2.7728, 0.130 82.39± 3.26 2.3435, 0.344
Power peak gamma 65.89± 3.76 61.21± 2.69 2.9971, 0.081 61.76± 2.40 2.2362, 0.421
CURRENT SOURCE DENSITY SIGNALS (CSDs)
Power delta (1–4Hz) 65.17± 3.13 71.70± 9.34 −1.9875, 0.642 66.53± 4.77 −0.5359, 6.003
Power theta (4–12Hz) 69.12± 4.94 71.18± 5.94 −0.7976, 4.367 69.80± 5.47 −0.2596, 7.989
Power gamma (20–90Hz) 67.82± 3.05 67.78± 2.89 0.0227, 9.821 67.20± 4.05 0.3476, 7.332
Theta/Delta 1.06± 0.05 1.00± 0.10 1.6182, 1.251 1.05± 0.05 0.2285, 8.225
Gamma/Delta 1.04± 0.04 0.96± 0.11 2.1969, 0.430 1.02±0.05 1.2373, 2.363
Gamma/Theta 0.98± 0.05 0.96± 0.05 1.1355, 2.728 0.96± 0.04 0.8062, 4.335
Frequency peak theta 5.4± 0.79 6.00± 0.52 −1.8973, 0.759 5.49± 0.63 −0.2334, 8.187
Frequency peak gamma 50.2± 0.01 47.42± 8.33 1.0000, 3.321 50.20± 0.01 0.0000, 10.000
Power peak theta 60.85± 5.38 62.72± 6.70 −0.6506, 5.244 61.27± 5.68 −0.1495, 8.832
Power peak gamma 56.35± 2.58 54.33± 3.64 1.3521, 1.951 56.48± 2.74 −0.0976, 4.235
Data are given as mean ± SD. Number of animals are indicated in brackets. The control group includes n = 7 non-manipulated mice plus 3 saline-injected animals.
All p-values are corrected for multiple comparisons (10). Comparisons with corrected p > 0.05 are shown in bold.
recordings (Figure 7B), potentially reflecting volume conducted
hippocampal activity (Vyazovskiy et al., 2002) and/or theta-phase
modulation entrainment of neocortical cells (Sirota et al., 2008).
Consistent with data under urethane anesthesia, we found lower
theta power in active E14 MAM-injected mice vs. control animals
(Figure 7B′). Attenuation of theta power was also detected in E14
MAM-injected mice in periods of REM sleep (Figures 7C,C′).
As described for urethane, the frequency of the exploratory
theta peak slightly accelerated in MAM E14 mice in comparison
with controls (Figure 7B′′), an effect not observed during REM
(Figure 7C′′). Therefore, attenuation of theta power appears to
be a feature of MAM-injected mice, probably reflecting a reduc-
tion of forebrain or topographic redistribution of EEG power
density as described in congenital models of callosal dysgenesis
(Vyazovskiy and Tobler, 2005).
Interestingly, we noted larger spindles in MAM E14-injected
mice vs. control animals during episodes of SWS and during SWS
to REM transition (Figures 8A,A′). This resulted in stronger spec-
tral power of SWS activity in the 10–16Hz band of the MAM
E14 group (Figures 8B,C), similar to abnormal spindle activity
in Williams syndrome and in a case of double cortex syndrome
(Sforza et al., 2010; Bódizs et al., 2012). Spindles inMAM-injected
mice were not evident during REM or wakefulness, and dur-
ing sleep they were typically associated to K-complexes (but not
always). Detection and spectral analysis of individual spindles
(Figure 8A′), showed they lasted longer (Figure 8D) and had
stronger spectral power (Figure 8E) in E14 MAM-injected vs. the
control group. Our surface macroelectrode data did not allow us
to reliably explore potential contribution from low-voltage and
high-voltage spindles (Johnson et al., 2010), and this is open to
further research. Spindle rate was not different between groups
(not shown). Abnormal spindle activity could be potentially asso-
ciated with other behavioral abnormalities in MAM models of
psychiatric disorders (Phillips et al., 2012).
CONVULSANT AGENT ADMINISTRATION DISCARDS
EPILEPSY-RELATED PHENOTYPES
Since thalamocortical spindle activity has been associated with
some forms of generalized epilepsy (Gloor and Fariello, 1988;
Danober et al., 1998), we tested whether MAM-injected ani-
mals were more sensitive to convulsants than control mice. We
chose to induce generalized-like seizures using pentylenetetra-
zol in a group of implanted animals (n = 7 MAM E14, n = 6
control) and temporolimbic-like seizures using pilocarpine injec-
tions (n = 7 MAM E14, n = 5 control) under EEG control. We
found no difference in the latency to status induced with lithium-
pilocarpine, neither in the time to the first electrographic seizures
with pentylenetetrazol (Table 2), in contrast to previous data
from transplacental MAMmodels and Dcx-KOmice (Chevassus-
Au-Louis et al., 1998a; Nosten-Bertrand et al., 2008). Of note, the
time to the first pilocarpine-induced seizure was longer in MAM-
injected mice and they exhibited fewer seizures before the status
onset as compared with control (Table 2), suggesting that once an
hyperexcitable state is reached they quickly progress into status.
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FIGURE 6 | Recordings from hippocampal heterotopias. (A) Potential
presence of epileptiform activity were evaluated in recordings restricted to
heterotopic clusters. In one case of mice injected at E14, the probe track
penetrated the CA1 heterotopia. Scale bar corresponds to 200µm. (A′) Local
field potentials (LFPs) during sharp-wave ripples and theta activity as
recorded from the mouse shown in (A). (A′′) The power spectrum at the
stratum lacunosum moleculare in this mouse was similar to the mean group
data of mice injected at E14. (B) One example of mouse injected at E15, in
which the probe passed through the CA1 heterotopia. Scale bar corresponds
to 200µm. (B′) LFPs recorded at different layers in the mouse shown in (B).
(B′′) Power spectra at the stratum lacunosum moleculare in the mouse
shown in (B) as compared with the corresponding mean group data for mice
injected at E15. (C) Example of electrode penetration through the CA3 double
layer in a MAM-injected mouse. Scale bar corresponds to 50µm. The red
discontinuous line marks the position of the probe track from where
recordings were analyzed. A parallel penetration is evident at the left. The
boxed region depicts an enlarged view of CA3. Scale bar corresponds to
100µm. (C′) Spatial distribution of MUA power spectrum from individual
cases penetrating the CA3 double layer. Data from 2 control
(non-manipulated) mice are shown.
This might be related with higher excitability of the model, as
confirmed with hippocampal I/O curves (Figure 4).
In view of these combined electrophysiological data we
conclude that intraventricularly MAM-injected mice were not
obviously prone to generalized and temporolimbic epilepsy,
in spite of a range of cortical and developmental hip-
pocampal malformations and structural similarities with other
epilepsy-prone models. Instead they exhibited a range of rhyth-
mopathies affecting thalamocortical and hippocampal activities.
DISCUSSION
We generated a model of cortical dysplasia in mice induced by
intraventricular MAM injection in utero aimed to gain better spa-
tiotemporal control of mitotoxic agents. Mice injected at E14 and
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FIGURE 7 | Chronic video-EEG recordings in freely moving mice. (A)
Video-EEG recordings were obtained to evaluate epileptiform activities and
to characterize the electrographic phenotype of MAM-injected animals.
For these recordings we used epidural screws implanted over the motor
cortex. A synchronizing LED (sync LED) was used to synchronize video
images and EEG recordings, allowing for behavioral and electrographic
definition of awake, REM and non-REM stages. (B) The mean power
spectra in periods of awake activity was dominated by theta-oscillations
in both groups. The discontinuous line represents the 95% confidence
interval. (B′) Group differences of theta power as evaluated from the
spectral area in the 4–10Hz band. (B′′) Group differences of theta
frequency. Similarly as recorded under urethane, we noted an
acceleration of the frequency peak. (C) The mean power spectra of EEG
signals in periods of REM sleep was also dominated by theta-oscillations.
(C’) Group differences of theta power in periods of REM as evaluated
from the spectral area in the 4–10Hz band. (C′′) Group differences of
theta frequency in periods of REM sleep. Data from n = 7 control
(non-manipulated mice), n = 7 MAM. ∗ (∗∗) stands for p < 0.05 (p < 0.01).
E15 exhibited a range of cortical and hippocampal malforma-
tions that recapitulate different histological phenotypes of specific
genetic mutations and transplacental injections. These include
nodular heterotopias in the cingulum, similar to the transplacen-
tal Ara-C and MAM model (Ono-Yagi et al., 2000; Tschuluun
et al., 2011); corpus callosum dysgenesis similar to congenitally
affected recombinant inbred lines (Schimanski et al., 2002) and
hippocampal malformations also present in Dcx- knockouts and
transplacental MAM injection (Ackman et al., 2009). In contrast
to most of these models, intraventricularly MAM-injected mice
were not more prone to epilepsy, in spite of enhanced hippocam-
pal excitability and a range of structural malformations. Instead
they showed non-specific reduction of the spectral power of
hippocampal-related brain oscillations, including theta, gamma
and HFOs; and longer and enhanced thalamocortical spindle
activity during non-REM sleep stages. We conclude that intra-
ventricular MAM in utero is a histological asymptomatic model
of cortical malformations exhibiting a range of rhythmopathies,
which can be further exploited to look at the complex interaction
between early disruptions of brain development and vulnerability
to later hits.
Malformations of cortical development are associated with a
variety of syndromes, including epilepsy, intellectual disabilities
and autism spectrum disorders. While many types of malforma-
tions are related to gene mutations, others are only defined based
on clinical criteria (Barkovich et al., 2012). However, there is no
clear separation between these categories. For instance, periven-
tricular heterotopias can be defined clinically with unknown
causes, or genetically with autosomal dominant inheritance
of different genes (Barkovich et al., 2012). Mutations of the
alpha tubulin 1A, LIS1 and doublecortin genes are all associ-
ated with classical forms of lissencephaly (Gleeson et al., 1998;
Keays et al., 2007; Wynshaw-Boris, 2007), with LIS1 and DCX
mutations causing different malformation gradients along the
fronto-occipital axis (Pilz et al., 1999). DCX mutations may also
course with intellectual disability and/or epilepsy giving raise to
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FIGURE 8 | Abnormal spindle activity during periods of non-REM
sleep. (A) Epidural EEG recordings in periods of non-REM sleep showed
altered spindles in MAM-injected mice. A K-complex and the associated
spindle are shown. (A′) Individual spindle events were detected and
analyzed to highlight group differences affecting duration and spectral
power in the 10–16Hz frequency band. (B) Group differences of the
mean power spectra in periods of non-REM sleep. The discontinuous line
represents the 95% confidence interval. (C) Group differences of theta
power as evaluated from the spectral area in the 10–13Hz band. (D)
Group differences of spindle duration. (E) Group differences of spindle
power. Data from n = 7 control (non-manipulated mice), n = 7 MAM.
(∗∗) stands for p < 0.05 (p < 0.01).
subcortical band heterotopia in females and also occasionally in
males (Guerrini et al., 2003). Mutations affecting microtubule
proteins, such as alpha tubulin 1A, are also associated with cor-
tical dysgenesis varying from mild to severe pachygyria with or
without corpus callosum dysgenesis and cerebellar hypoplasia
(Kumar et al., 2010). Neurological disorders associated with this
mutation vary substantially, from moderate to severe intellec-
tual disability with or without refractory epilepsy (Bahi-Buisson
et al., 2008). Possibly, LIS1, DCX, and alpha tubulin 1A muta-
tions have different phenotypes because the ultimate phenotype
depends upon the precise mutation, the effects of the mutation
on the structure of the molecular product of the gene and the
effects of the altered structure of the molecular product on the
molecular function in the molecular pathway under epigenetic
influences (Dempster et al., 2011; Feil and Fraga, 2012; Bahi-
Buisson et al., 2013). Furthermore, single-nucleotic variations,
somatic mutations and constitutional aneuploidy in the normal
human brain may also contribute to heterogeneous phenotypes
and functional diversity (Rehen et al., 2005; Poduri et al., 2013).
This reflects the intrinsic complexity of neurodevelopmental
disorders.
Our data suggest that cortical developmental malformations
do not necessarily correlate with major brain malfunction. This
would suggest that imaging studies (PET, fMRI) in people suf-
fering from epilepsy, excluding idiopathic epilepsies, may not be
fully informative in some cases (Duncan, 1997; King et al., 1998).
However, some experimental studies (Manent et al., 2009; Lapray
et al., 2010) demonstrated good relationship between the size
and location of the malformation with the functional deficits.
This is consistent with the fact that some but not all forms of
focal cortical dysplasia represent neuropathological entities with
specific neuroimaging and electrographic features (Tassi et al.,
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Table 2 | Characterization of seizure progression and susceptibility to
pilocarpine and pentylenetetrazol systemic injections.
E14 MAM-injected Control
LITHIUM-PILOCARPINE
Time to first electrographic seizure (sec) 1045± 469 640± 117*
Total number of seizures before status 0.8± 0.8 2± 0.6*
Status onset (sec) 1089± 575 1533± 572
% of resistant mice 1/7 0/6
PENTYLENETETRAZOL
Time to first electrographic seizure (sec) 177± 87 232± 185
First seizure duration (sec) 21± 5 19± 2
% of resistant mice 1/7 1/5
Data are represented as mean ± SD. * stands for p < 0.05 for two-tailed t-test
statistical comparisons between groups. The control group include only non-
manipulated mice.
2002; Urbach et al., 2002). Possibly, the true relationship between
anatomical alterations and brain function is hidden in the asymp-
tomatic human population that has not reached the diagnostic
threshold of a developmental brain disorder.
The absence of any obvious seizure-related pheno-
type in MAM-injected mice, neither spontaneously nor
pharmacologically-induced, appears at odds with previous
models. Decreased seizure thresholds have been reported for
transplacental MAM models using a variety of convulsants
to trigger generalized, limbic-like or secondarily generalized
seizures (Baraban and Schwartzkroin, 1996; Germano and
Sperber, 1997; Chevassus-Au-Louis et al., 1998a). Most of these
experiments have been carried on rats, and potential species
and genetic background factors could explain differences (Xu
et al., 2004). Dcx-KO mice carrying the CA3-double layer and
enhanced excitability can express both spontaneous seizures and
a higher susceptibility to kainate- and pentylenetetrazol-induced
seizures (Nosten-Bertrand et al., 2008). This appears consistent
with the increased hippocampal excitability in these models,
as tested both in vitro (Avoli et al., 1999; Colacitti et al., 1999;
Baraban et al., 2000; Bazelot et al., 2012) and in vivo (Figure 4).
Also, Lapray et al. (2010) using an acute Dcx RNA interference
model showed a correlation between the size of neocortical
heterotopias and seizure severity. However, several other models
show dissociation between the presence of heterotopias and the
epileptic phenotype, i.e., the Eker rat model of tuberous sclerosis
showed no spontaneous seizure activity and a similar seizure
threshold compared to control animals (Wenzel et al., 2004;
Tschuluunm et al., 2007). Therefore, developmental dysplastic
lesions appear to be not necessarily epileptogenic. Possibly,
dampened hippocampal rhythms and abnormal thalamocortical
spindles recorded in our model could be related with cognitive
impairment associated with rhythmopathies in neurodevel-
opmental disorders and epilepsy (Uhlhaas and Singer, 2012;
Inostroza et al., 2013).
The debate is open for alternative explanations and concepts.
One possibility is that it is the interaction between het-
erotopias and the surrounding circuits that controls epilep-
togenesis (Chevassus-Au-Louis et al., 1998b; Kitaura et al.,
2012; Schwartzkroin and Wenzel, 2012). Concerning Dcx RNAi
induced neocortical heterotopias, Ackman et al showed synchro-
nization between the heterotopia and the overlying hyperex-
citable cortex, similar to data in subcortical band patients by
Kobayashi et al. (2006). This suggests that abnormal connec-
tivity in terms of excitatory circuits and GABAergic inhibitory
control could potentially underlie hyperexcitability in epilep-
togenic regions (Roper et al., 1999; Sarkisian et al., 2001;
Menendez de la Prida et al., 2002; Alonso-Nanclares et al.,
2005; Calcagnotto et al., 2005; Poluch et al., 2008). Hence,
understanding altered connectivity and transmission within dys-
plastic regions and with other brain areas, may be critical to
understand resistance to epilepsy given the role of interneurons
in controlling the expression of epileptic phenotypes (Lodato
et al., 2011; Powell, 2013). Possibly, interfering roles of inde-
pendent epileptogenic circuitries could also account for this, as
in the case of thalamocortical and corticolimbic circuits which
are proposed to mutually inhibit each other (Es˛kazan et al.,
2002; Gurbanova et al., 2008). We indeed found here longer
and stronger thalamocortical spindle activity in MAM-injected
mice (Figure 8), which could potentially modulate hippocampal
hyperexcitability.
Alternatively, it is possible that the diffuseness of cortical
malformations disrupts the natural propagation pathways of neu-
ronal activity therefore segregating local enhanced excitability
to dysplastic regions. For instance, many cortical malforma-
tions are typically associated with corpus callosum dysgenesis
(Raybaud, 2010), as we also found in intraventricularly MAM-
injected mice (Figure 2). This, together with haphazard dyslam-
ination of neocortical layer II, could potentially impair activity
spread and reverberation in a critical mass of affected circuitries.
Interestingly, partial agenesis of the corpus callosum and the
position of heterotopia appear to modulate seizure susceptibil-
ity (Gabel et al., 2013). Notably Dcx KO mice on the C57BL/6J
background studied here have an intact corpus callosum
(Kappeler et al., 2007).
The expression of a particular clinical phenotype could
strongly depend on co-existing pathologies in interaction with
environmental factors, as suggested from case reports of polymi-
crogyria (Barkovich et al., 1995) and of focal dysplasia and
hippocampal sclerosis with a history of febrile seizures (Lévesque
et al., 1991; Fauser et al., 2006; Gibbs et al., 2011). Similarly,
tuberous sclerosis is associated with very high risk of autism
spectrum disorders when tubers in the temporal lobe are associ-
ated with early-onset seizure activity (Bolton et al., 2002; Numis
et al., 2011). In a postnatal freeze lesion model of polymicrogyria,
epileptiform activity is recorded adjacent to the lesion but not
in the microgyrus itself (Jacobs et al., 1996). This model shows
surprisingly widespread cortical modifications in receptor den-
sity (Zilles et al., 1998) and GABA receptor subunits (Redecker
et al., 2000), although the anatomical lesion (microgyrus) is very
local. Interestingly, freeze lesions appear to become epileptogenic
when they are executed prenatally in utero (Takase et al., 2008)
suggesting that the timing of brain malformations is a critical
factor.
Different animal models of malformations of cortical develop-
ment are thus key tools to better understand these associations.
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Both genetic and pharmacological approaches have been used
extensively to determine which proteins and pathways play roles
in the intricate processes of brain development. Yet, while our
understanding of the normal developmental program is more
sophisticated (Rubenstein and Rakic, 2013), we still lack a holis-
tic view of the diseased developmental brain. What determines
the expression of a particular neurological feature in associa-
tion with a particular form of cortical malformation? What is
the relative contribution of genetic and environmental factors?
Are there common signaling pathways underlying different types
of cortical malformations? These questions incite the identifi-
cation of new models for more accurate clinical definitions. To
account for the genetic, developmental and clinical complex-
ity of cortical malformations, models should probably allow an
independent early brain disruption with a late second hit. This
two-hit approach is now being considered to better model com-
plex diseases like cancer and schizophrenia, which are linked to
several genetic and environmental factors. The intraventricular
MAM model of cortical dysplasia with hippocampal and tha-
lamocortical rhythmopathies could be combined with genetic
and seizure susceptibility models to study associated neurolog-
ical disorders. This could include using intraventricular MAM
injection in modified genetic backgrounds (e.g., upstream to the
mammalian target of rapamycin mTOR cascade; Baybis et al.,
2004; Orlova et al., 2010) and the manipulation of environ-
mental factors (stress, seizure induction, hyperthermia, etc.) to
causally test and to dissect out critical signaling pathways and syn-
dromes underlying the wide spectrum of developmental cortical
malformations.
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Supplementary Figure 1 | Paired-pulse inhibition and facilitation. (A) (Left)
Paired-pulse inhibition (using maximal stimulation intensities) of the
second response at inter-pulse intervals of 25, 50, 75, 100, 125, and
150ms was used to probe for inhibitory circuits in different groups of
animals, including doublecortin knockouts (Dcx-KO). (Right), No
differences were evident between groups. Data from n = 9 control
(non-manipulated), n = 6 MAM and n = 7 Dcx-KO. Saline-injected mice
were similar to control. (B) (Left) Paired-pulse facilitation (using stimulation
intensities of 40% of the maximal response) of the second response was
used to probe for differences on presynaptic release. (Right), No clear
differences emerged between groups. Data from n = 7 control
(non-manipulated), n = 8 MAM and n = 8 Dcx-KO. Saline-injected mice
were similar to control.
Supplementary Figure 2 | Electrophysiological recordings in E15
MAM-injected mice under urethane. (A) Relationship between the
amplitude of the fEPSP and stimulation intensity. Data from n = 11 control
(non-manipulated), n = 5 MAM, and n = 7 Dcx-KO. (A′) Relationship
between the amplitude of the afferent volley (AV) and stimulation
intensity. (A′′) Input/output curves suggesting slightly higher excitability in
E15 MAM-treated mice as compared to control. Data in (A′,A′′) are from
n = 5 control (non-manipulated), n = 3 MAM, and n = 3 Dcx-KO.
Saline-injected (sham) mice were similar to control. (B) Group data on
paired-pulse facilitation (n = 7 control, n = 5 MAM, and n = 8 Dcx-KO).
(B′) Group data on paired-pulse inhibition. (n = 9 control non-manipulated
mice, n = 4 MAM, and n = 7 Dcx-KO). No differences were found
between groups. Saline-injected (sham) mice were similar to control. (C)
Mean power spectrum data from control (black, n = 10 non-manipulated
mice) and E15 MAM-injected mice (blue, n = 5) as recorded at the slm
electrode. Discontinuous line represents 95% confidence interval. Note
deviation from 1/f noise in all cases, and dominant peaks at theta (4–6Hz)
and gamma (30–40Hz) frequency. (C′) Spatial distribution of the
normalized (1/f corrected) theta power area (4–10Hz) around the stratum
lacunosum moleculare (taken as reference). There is statistical difference
between groups especially at CA1 [F(1, 7) = 32.03; p < 0.001]. Inset plots
group data on theta frequency peak showed no difference at the stratum
lacunosum moleculare. (C′′) Spatial distribution of the gamma power area
(30–90Hz) around the slm channel (taken as reference) showed
differences between groups [F(1, 7) = 44.87, p < 0.001]. The inset plots
group differences of gamma frequency peak. (D) Potential differences of
sharp-wave ripple events in control and E15 MAM-injected mice.
High-frequency oscillations (ripples) at 100–150Hz were maximal around
the stratum pyramidale. (D′) Similar to E14 injected mice, ripple power
was strongly reduced in E15 MAM-injected animals. (D′′) No group
differences were found in ripple duration. Data from n = 10 (463 events)
control (non-manipulated mice), n = 5 (224 events) MAM, and n = 5 (217
events) Dcx-KO.
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